About us

Our Vision

Our vision is to consistently be a leader in the European IVF market through care, innovation, and research. We achieve this by staying at the forefront of the latest treatment methods, based on ongoing research and development, and by making them accessible to as many involuntarily childless couples and women as possible.

By being the most successful and highly regarded IVF organization in the Nordic region, we are also the most attractive employer within both private and public IVF operations in our market.

Our mission

To achieve our vision, we continuously work with our quality system and are deeply committed to ongoing research and development. In addition, Livio is part of a network, IVI RMA, which enables professional development for our staff, access to the latest research, and the very latest technology in reproductive medicine.

Our History

At the beginning of the 2000s, in vitro fertilization (IVF) was still a medical practice that operated quietly. With changing lifestyle factors and people having children later in life, the general demand for IVF steadily increased. However, public healthcare did not have the resources to help all involuntarily childless couples, and waiting times could be several years.

IVF-kliniken Stockholm AB, now Livio AB, was founded in 2000 by Dr. Steffan Lundberg and Associate Professor Håkan Wramsby to increase access to IVF in the Stockholm area. Over the years, increased accessibility, simplified treatment processes for patients, and the dissemination of the latest IVF expertise in Sweden have been guiding principles for the owners and founders.

Today, the group performs about 8,500 IVF treatments at nine clinics in Sweden, Norway, and Iceland, making the Livio Group the largest player in the Nordics in assisted reproduction and reproductive medicine.

Timeline

• 2000: IVF-kliniken Stockholm AB is founded.

• 2002: IVF-kliniken Umeå at Norrland University Hospital, with a donation program, is acquired.

• 2003: IVF-kliniken Cura in Malmö becomes part of the group.

• 2008: The Promobilia Foundation, which supports the development of technical aids for people with disabilities, becomes a shareholder.

• 2008: IVF-kliniken Falun, with a well-developed organization for remote treatment, is acquired.

• 2008: The business doubles in size with the acquisition of the renowned Fertilitetscentrum, with clinics in Gothenburg and Stockholm.

• 2008: IVF Research Sweden (now Livio Research) is launched.

• 2011: IVF-kliniken Stockholm AB changes its name to IVF Sverige AB.

• 2012: IVF-kliniken Öresund is acquired and, together with IVF-kliniken Cura, forms the new clinic IVF-kliniken CuraÖresund.

• 2014: IVF Sverige acquires IVF-klinikken Oslo, one of the oldest and leading clinics in Norway.

• 2016: IVF Sverige starts IVF-klíníkin Reykjavík in Iceland, in collaboration with prominent names in reproductive medicine who previously worked at Art Medica Clinic in Reykjavik.

• 2017: IVF Sverige AB acquires part of the IVF group at Sophiahemmet.

• 2018: IVF Sverige, Fertilitetscentrum Gothenburg and Stockholm, and IVF clinics in Falun, Malmö, Umeå, Stockholm, Oslo, and Reykjavik rebrand all operations under the common name Livio.

• 2019: Livio Egg and Sperm Bank is established in Sweden and begins successful recruitment of new donors to significantly reduce waiting times for donation treatments, initially in Sweden.

• 2020: Livio Egg and Sperm Bank Iceland is established.

• 2023: The Livio Group becomes part of IVI RMA, the world’s largest IVF provide